CVTX Insider Trading Activity and SEC Form 4 Filings
CVTX insider trading summary
No open-market insider purchases or sales of Cv Therapeutics Inc (CVTX) have been reported on SEC Form 4 in the past 12 months.
Latest CVTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 2, 2009 | Daniel K Spiegelman | SVP, CFO | Sell | $1.2M (59,423 @ $19.91) |
| Apr 2, 2009 | Daniel K Spiegelman | SVP, CFO | Sell | $238K (11,969 @ $19.91) |
| Apr 2, 2009 | Louis G Lange | Chairman & CEO | Sell | $914K (45,929 @ $19.90) |
| Apr 2, 2009 | Louis G Lange | Chairman & CEO | Sell | $2.8M (138,615 @ $19.90) |
| Apr 2, 2009 | Louis G Lange | Chairman & CEO | Sell | $321K (16,154 @ $19.90) |
| Apr 2, 2009 | Daniel K Spiegelman | SVP, CFO | Sell | $1.4M (69,637 @ $19.91) |
| Apr 2, 2009 | Louis G Lange | Chairman & CEO | Sell | $5.5M (278,477 @ $19.90) |
| Feb 6, 2009 | Brent K Blackburn | SVP, Drug Discovery & Dev | Sell | $23K (1,500 @ $15.50) |
| Jan 7, 2009 | Brent K Blackburn | SVP, Drug Discovery & Dev | Sell | $14K (1,500 @ $9.38) |
| Dec 10, 2008 | Lewis J Stuart | SVP Commercial Operations | Sell | $9K (1,002 @ $9.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.